MRI and biopsy study of how prostate tumors grow
Part of Cancer, Kidney & urinary clinical trials.
This study looks at whether special MRI details can help predict how invasive your prostate cancer tumor is. It combines MRI images with your biopsy results to see if MRI patterns can match how aggressive the cancer may be.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can have a prostate MRI scan on a 3T machine at Halifax Infirmary within 5 weeks of starting the study
- Your MRI must show a prostate cancer–related nodule that matches what the biopsy finds
- Your biopsy must be done within 2 months before/after your first MRI, and no later than 3 months after study enrollment
- Your biopsy report must confirm prostate cancer and include at least 12 tissue samples (cores)
- The biopsy must find at least one cancer core that lines up with the nodule seen on the first MRI
- You should not have had prior prostate procedures that could change prostate structure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses repeat MRI scans to monitor men with an intermediate suspicion of prostate cancer, aiming to reduce unnecessary biopsies while still catching significant cancers early.
This study uses a special kind of MRI to better “map” prostate cancer inside the prostate. Researchers compare the MRI results with the detailed tissue exam after prostate surgery to see how accurate the imaging is.
This trial uses advanced MRI scans and detailed tissue analysis to better detect prostate cancer. It is for people with confirmed prostate cancer who are already scheduled for prostate removal surgery.
This study checks whether a detailed MRI method can help find prostate cancer earlier in people considered high risk. You may be asked to get an MRI and help the team see if it works well as a screening test.
This study compares how well a doctor’s MRI reading (the PI-RADS score) and a computer AI tool detect prostate cancer. It may help improve how men get targeted biopsies and avoid missing important cancers.
This study tests a new MRI platform to better identify prostate issues before a biopsy. It is for people with elevated PSA whose doctor is considering a biopsy.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.